Theravance Biopharma, Inc. (TBPH)
13.93
+0.15
(+1.09%)
USD |
NASDAQ |
Mar 16, 16:00
13.91
-0.02
(-0.14%)
Pre-Market: 08:43
Theravance Biopharma Total Assets (Quarterly) : 415.46M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Integer Holdings Corp. | 3.411B |
| QuidelOrtho Corp. | 5.769B |
| Nektar Therapeutics | 280.41M |
| Innoviva, Inc. | 1.635B |
| CorMedix, Inc. | 877.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 182.78M |
| Shareholders Equity (Quarterly) | 232.68M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |